Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CNTX-6970 by Centrexion Therapeutics for Osteoarthritis Pain: Likelihood of Approval
CNTX-6970 is under clinical development by Centrexion Therapeutics and currently in Phase II for Osteoarthritis Pain. According to GlobalData, Phase...